-
FOXO3-Mediated Dual Metabolic Inhibition in Hepatocellular C
2026-07-28
The reference study reveals how FOXO3 suppresses both glycolysis and glutaminolysis in hepatocellular carcinoma by directly repressing YAP transcription. This mechanistic insight proposes dual metabolic pathway inhibition as a promising strategy for metabolic-based HCC intervention.
-
Drimartol B Induces Apoptosis by Targeting AKT1-Glycolysis i
2026-07-28
This study identifies drimartol B, a sesquiterpene from Artemisia sphaerocephala, as a potent inducer of apoptosis in colorectal cancer cells. By suppressing the AKT1/GLUT1/HK2 pathway and disrupting glycolysis, drimartol B provides a mechanistic foundation for novel CRC therapies with reduced toxicity.
-
Octenidine Dihydrochloride: Membrane Mechanisms & Lab Innova
2026-07-27
Explore Octenidine dihydrochloride’s unique membrane-disruptive mechanism and its pivotal role as an antiseptic research compound. This article offers advanced scientific insights and practical assay guidance, setting it apart from existing reviews.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody: Protocols & QC Guide
2026-07-27
The HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) enables sensitive and specific detection of mouse primary antibodies in immunoassays such as Western blot, ELISA, IHC, and ICC. This reagent is best suited for workflows requiring reliable signal amplification using horseradish peroxidase conjugation. It should not be used for non-mouse primary antibodies or in protocols incompatible with HRP enzymatic detection systems.
-
WM-8014: Precision KAT6A Inhibitor for Senescence Workflows
2026-07-26
WM-8014 delivers unrivaled selectivity for KAT6A/B, empowering researchers to dissect epigenetic mechanisms of oncogene-induced senescence with high reproducibility and minimal cytotoxicity. This article details workflow enhancements, troubleshooting guidance, and actionable protocol parameters to elevate cancer biology research using this advanced inhibitor.
-
β-Amanitin in RNA Polymerase II Studies: Protocols & Innovat
2026-07-25
Harness β-Amanitin’s precise RNA polymerase II inhibition for unparalleled insight into transcriptional regulation and high-sensitivity toxin detection. This article bridges practical protocols, advanced assay design, and troubleshooting strategies, ensuring researchers leverage APExBIO’s β-Amanitin for robust results.
-
CCT007093: Applied Workflows for PPM1D Inhibitor Research
2026-07-24
CCT007093 enables precise modulation of the PPM1D signaling pathway, driving robust activation of P38 MAPK and facilitating mechanistic dissection of pyroptosis and selective cytotoxicity in disease models. Its DMSO-only solubility and pathway specificity make it a top choice for targeted pathway studies and translational research.
-
Ziprasidone Hydrochloride (A5350): Reliable Assays in Oncolo
2026-07-24
This article delivers a scenario-driven exploration of Ziprasidone Hydrochloride (SKU A5350), demonstrating its reliability in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and real laboratory pain points, it provides actionable insights and protocol recommendations for biomedical researchers and lab technicians, with practical vendor comparisons and links to validated protocols.
-
Applied Workflows with Recombinant Human EGF in 3D Tumor Sph
2026-07-23
Leverage recombinant human EGF to enhance 3D glioblastoma spheroid assays and mucosal healing models. This guide delivers actionable workflows, troubleshooting insights, and experimental benchmarks, all grounded in high-purity APExBIO EGF for reproducible, translational results.
-
Sumatriptan Succinate: Metabolic Mechanisms and Research Des
2026-07-23
Explore the advanced metabolic pathways of Sumatriptan Succinate as a 5-HT1 receptor agonist, delving into enzyme-specific mechanisms and their impact on experimental strategies. This article uniquely bridges metabolic insight with practical guidance for migraine and inflammation research.
-
CD28-ARS2 Axis Drives PKM Splicing for CD8+ T Cell Metabolic
2026-07-22
This study uncovers how the CD28-ARS2 signaling axis in CD8+ T cells orchestrates alternative splicing of pyruvate kinase M (PKM), promoting the PKM2 isoform and enhancing antitumor immunity. These findings reveal a new layer of posttranscriptional metabolic regulation in T cell function with broad implications for immunometabolic research.
-
Omeprazole (A2845) as a H+,K+-ATPase Inhibitor in Gastric Ac
2026-07-22
Omeprazole (SKU A2845) is a highly pure H+,K+-ATPase inhibitor designed for in vitro and ex vivo research on gastric acid secretion and antiulcer activity. It is not intended for clinical, diagnostic, or therapeutic use, but is optimized for mechanistic studies and assay development in gastric acid-related models.
-
Anti-ROR1 Antibody (Zilovertamab): Applied Workflows in Live
2026-07-21
Anti-ROR1 Antibody (Zilovertamab) from APExBIO enables precise targeting of Wnt5a-induced ROR1 signaling, unlocking new experimental designs in liver injury and cancer research. Its validated performance across ELISA, FACS, and functional assays delivers reproducible, high-specificity results and actionable troubleshooting insights.
-
CTCF Maintains Centromere Function and Ensures Mitotic Fidel
2026-07-21
This study elucidates the essential role of CTCF in maintaining centromere integrity and accurate chromosome segregation during mitosis. By employing rapid CTCF degradation, the authors reveal a mechanism distinct from CENP-E recruitment, with direct implications for understanding mitotic errors in disease.
-
2-NBDG Glucose Uptake Assay Kit: Precision in Cellular Metab
2026-07-20
The 2-NBDG Glucose Uptake Assay Kit enables rapid, non-radioactive, and highly sensitive quantification of glucose uptake at single-cell resolution. Its use of the 2-NBDG fluorescent glucose analogue and GLUT1 inhibitor phloretin allows for specific and reproducible metabolic analyses. This product sets a new standard for research on glucose metabolism in cancer, diabetes, and obesity.